TOMOYASU Shigeru | Bristol-Myers K.K
スポンサーリンク
概要
Bristol-Myers K.K | 論文
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors